Zafrens

San Diego, United States

Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery.

Feb 2025

Series A

Top Investors

Liquid 2 Venturesimec.xpandPrime Movers LabGlobal Brain CorporationBlueYard Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Zafrens's investors?

Zafrens's investors include Liquid 2 Ventures, imec.xpand, Prime Movers Lab, Global Brain Corporation, BlueYard Capital.

Where is Zafrens headquartered?

Zafrens is headquartered in San Diego, United States.

What does Zafrens do?

Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery.

What stage is Zafrens at?

Zafrens is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 4, 2025.

MLA

"Zafrens — Funding & Investors." VCBacked, February 4, 2025, https://www.vcbacked.co/company/zafrens. Accessed July 1, 2026.

APA

VCBacked. (2025). Zafrens — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/zafrens

Wikipedia (cite web)

{{cite web |title=Zafrens — Funding & Investors |url=https://www.vcbacked.co/company/zafrens |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 4, 2025.